Severe Type 2 Diabetes Induces Reversible Modifications of Endothelial Progenitor Cells Which are Ameliorate by Glycemic Control

doi:10.15283/ijsc.2016.9.1.137

. 2016 May 30;9(1):137-44.

doi: 10.15283/ijsc.2016.9.1.137.

Severe Type 2 Diabetes Induces Reversible Modifications of Endothelial Progenitor Cells Which are Ameliorate by Glycemic Control

Affiliations

¹ U.O.C. Division of Immunohematology, Transfusion Medicine and Transplant Immunology, Department of Internal Medicine and Specialistics, Azienda Ospedaliera Universitaria, Second University of Naples.
² Division of Cardiology, ASL NA1, Pellegrini Hospital, Naples, Italy.
³ Department of Anesthesia and Critical Care Medicine, University of Florida, Shands Hospital, Florida, USA.
⁴ Department of Medicine and Surgery, Plastic Surgery Unit, University of Salerno, Salerno, Italy.
⁵ Department of Medical, Surgical, Neurological, Aging and Metabolic Sciences, Second University of Naples, Naples, Italy.
⁶ IRCCS Foundation SDN, Naples, Italy.
⁷ Geriatrics Medicine, Department of Translational Medical Science, Federico II University of Naples, Naples, Italy.

PMID: 27426095
PMCID: PMC4961113
DOI: 10.15283/ijsc.2016.9.1.137

Severe Type 2 Diabetes Induces Reversible Modifications of Endothelial Progenitor Cells Which are Ameliorate by Glycemic Control

Maria Rosaria De Pascale et al. Int J Stem Cells. 2016.

. 2016 May 30;9(1):137-44.

doi: 10.15283/ijsc.2016.9.1.137.

Authors

Affiliations

¹ U.O.C. Division of Immunohematology, Transfusion Medicine and Transplant Immunology, Department of Internal Medicine and Specialistics, Azienda Ospedaliera Universitaria, Second University of Naples.
² Division of Cardiology, ASL NA1, Pellegrini Hospital, Naples, Italy.
³ Department of Anesthesia and Critical Care Medicine, University of Florida, Shands Hospital, Florida, USA.
⁴ Department of Medicine and Surgery, Plastic Surgery Unit, University of Salerno, Salerno, Italy.
⁵ Department of Medical, Surgical, Neurological, Aging and Metabolic Sciences, Second University of Naples, Naples, Italy.
⁶ IRCCS Foundation SDN, Naples, Italy.
⁷ Geriatrics Medicine, Department of Translational Medical Science, Federico II University of Naples, Naples, Italy.

PMID: 27426095
PMCID: PMC4961113
DOI: 10.15283/ijsc.2016.9.1.137

Abstract

Background: Circulating endothelial progenitors cells (EPCs) play a critical role in neovascularization and endothelial repair. There is a growing evidence that hyperglycemia related to Diabetes Mellitus (DM) decreases EPC number and function so promoting vascular complications.

Aim of the study: This study investigated whether an intensive glycemic control regimen in Type 2 DM can increase the number of EPCs and restores their function.

Methods: Sixty-two patients with Type 2 DM were studied. Patients were tested at baseline and after 3 months of an intensive regimen of glycemic control. The Type 2 DM group was compared to control group of subjects without diabetes. Patients with Type 2 DM (mean age 58.2±5.4 years, 25.6% women, disease duration of 15.4±6.3 years) had a baseline HgA1c of 8.7±0.5% and lower EPC levels (CD34+/KDR+) in comparison to healthy controls (p<0.01).

Results: The intensive glycemic control regimen (HgA1c decreased to 6.2±0.3%) was coupled with a significant increase of EPC levels (mean of 18%, p<0.04 vs. baseline) and number of EPCs CFUs (p<0.05 vs. baseline).

Conclusion: This study confirms that number and bioactivity of EPCs are reduced in patients with Type 2 DM and, most importantly, that the intensive glycemic control in Type 2 DM promotes EPC improvement both in their number and in bioactivity.

Keywords: Endothelial progenitor cells; Regenerative medicine; Type 2 diabetes; Vascular disease.

PubMed Disclaimer

Figures

**Fig. 1**
Number of EPCs positive to FACS and EPCs positive to chemotaxic assay for VEGF-A in healthy group vs type 2 DM patients pre- and after glycemic control.

See this image and copyright information in PMC

Cited by

Stem cell properties of peripheral blood endothelial progenitors are stimulated by soluble CD146 via miR-21: potential use in autologous cell therapy.
Essaadi A, Nollet M, Moyon A, Stalin J, Simoncini S, Balasse L, Bertaud A, Bachelier R, Leroyer AS, Sarlon G, Guillet B, Dignat-George F, Bardin N, Blot-Chabaud M. Essaadi A, et al. Sci Rep. 2018 Jun 20;8(1):9387. doi: 10.1038/s41598-018-27715-4. Sci Rep. 2018. PMID: 29925894 Free PMC article.
Stem Cell-Based Therapy: A Promising Treatment for Diabetic Foot Ulcer.
El Hage R, Knippschild U, Arnold T, Hinterseher I. El Hage R, et al. Biomedicines. 2022 Jun 25;10(7):1507. doi: 10.3390/biomedicines10071507. Biomedicines. 2022. PMID: 35884812 Free PMC article. Review.
Endothelial Progenitor Cells: An Appraisal of Relevant Data from Bench to Bedside.
Morrone D, Picoi MEL, Felice F, De Martino A, Scatena C, Spontoni P, Naccarato AG, Di Stefano R, Bortolotti U, Dal Monte M, Pini S, Abelli M, Balbarini A. Morrone D, et al. Int J Mol Sci. 2021 Nov 28;22(23):12874. doi: 10.3390/ijms222312874. Int J Mol Sci. 2021. PMID: 34884679 Free PMC article. Review.
Effect of glycemic control on markers of subclinical atherosclerosis in patients with type 2 diabetes mellitus: A review.
Antoniou S, Naka KK, Papadakis M, Bechlioulis A, Tsatsoulis A, Michalis LK, Tigas S. Antoniou S, et al. World J Diabetes. 2021 Nov 15;12(11):1856-1874. doi: 10.4239/wjd.v12.i11.1856. World J Diabetes. 2021. PMID: 34888012 Free PMC article. Review.
Low Phosphatidylserine+ Cells Within the CD34+/CD45dim/CD117(c-kit)+ Subpopulation Are Associated with Poor Outcomes in Metastatic Colorectal Cancer.
Brocco D, Simeone P, Marino PD, De Bellis D, D'Ascanio F, Colasante G, Grassadonia A, De Tursi M, Florio R, Di Ianni M, Cama A, Tinari N, Lanuti P. Brocco D, et al. Cancers (Basel). 2025 Feb 2;17(3):499. doi: 10.3390/cancers17030499. Cancers (Basel). 2025. PMID: 39941866 Free PMC article.

See all "Cited by" articles

References

1. Sommese L, Vasco M, Costa D, Napoli C. Endothelial progenitor cells and human diseases. Ann Hematol. 2014;93:533–534. doi: 10.1007/s00277-013-1840-z. - DOI - PubMed
1. Napoli C, Hayashi T, Cacciatore F, Casamassimi A, Casini C, Al-Omran M, Ignarro LJ. Endothelial progenitor cells as therapeutic agents in the microcirculation: an update. Atherosclerosis. 2011;215:9–22. doi: 10.1016/j.atherosclerosis.2010.10.039. - DOI - PubMed
1. Wojakowski W, Kucia M, Kaźmierski M, Ratajczak MZ, Tendera M. Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism? Heart. 2008;94:27–33. doi: 10.1136/hrt.2006.103358. - DOI - PubMed
1. Liguori A, Fiorito C, Balestrieri ML, Crimi E, Bruzzese G, Williams-Ignarro S, D’Amora M, Sommese L, Grimaldi V, Minucci PB, Giovane A, Farzati B, Ignarro LJ, Napoli C. Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease. Eur J Haematol. 2008;80:258–264. doi: 10.1111/j.1600-0609.2007.01007.x. - DOI - PubMed
1. Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P, Bugli AM, Bragotti LZ, Francolini G, Mauro E, Castoldi G, Ferrari R. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation. 2004;110:1209–1212. doi: 10.1161/01.CIR.0000136813.89036.21. - DOI - PubMed

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Research Materials
- NCI CPTC Antibody Characterization Program

[1] Sommese L, Vasco M, Costa D, Napoli C. Endothelial progenitor cells and human diseases. Ann Hematol. 2014;93:533–534. doi: 10.1007/s00277-013-1840-z. - DOI - PubMed

[2] Sommese L, Vasco M, Costa D, Napoli C. Endothelial progenitor cells and human diseases. Ann Hematol. 2014;93:533–534. doi: 10.1007/s00277-013-1840-z. - DOI - PubMed

[3] Napoli C, Hayashi T, Cacciatore F, Casamassimi A, Casini C, Al-Omran M, Ignarro LJ. Endothelial progenitor cells as therapeutic agents in the microcirculation: an update. Atherosclerosis. 2011;215:9–22. doi: 10.1016/j.atherosclerosis.2010.10.039. - DOI - PubMed

[4] Napoli C, Hayashi T, Cacciatore F, Casamassimi A, Casini C, Al-Omran M, Ignarro LJ. Endothelial progenitor cells as therapeutic agents in the microcirculation: an update. Atherosclerosis. 2011;215:9–22. doi: 10.1016/j.atherosclerosis.2010.10.039. - DOI - PubMed

[5] Wojakowski W, Kucia M, Kaźmierski M, Ratajczak MZ, Tendera M. Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism? Heart. 2008;94:27–33. doi: 10.1136/hrt.2006.103358. - DOI - PubMed

[6] Wojakowski W, Kucia M, Kaźmierski M, Ratajczak MZ, Tendera M. Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism? Heart. 2008;94:27–33. doi: 10.1136/hrt.2006.103358. - DOI - PubMed

[7] Liguori A, Fiorito C, Balestrieri ML, Crimi E, Bruzzese G, Williams-Ignarro S, D’Amora M, Sommese L, Grimaldi V, Minucci PB, Giovane A, Farzati B, Ignarro LJ, Napoli C. Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease. Eur J Haematol. 2008;80:258–264. doi: 10.1111/j.1600-0609.2007.01007.x. - DOI - PubMed

[8] Liguori A, Fiorito C, Balestrieri ML, Crimi E, Bruzzese G, Williams-Ignarro S, D’Amora M, Sommese L, Grimaldi V, Minucci PB, Giovane A, Farzati B, Ignarro LJ, Napoli C. Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease. Eur J Haematol. 2008;80:258–264. doi: 10.1111/j.1600-0609.2007.01007.x. - DOI - PubMed

[9] Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P, Bugli AM, Bragotti LZ, Francolini G, Mauro E, Castoldi G, Ferrari R. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation. 2004;110:1209–1212. doi: 10.1161/01.CIR.0000136813.89036.21. - DOI - PubMed

[10] Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P, Bugli AM, Bragotti LZ, Francolini G, Mauro E, Castoldi G, Ferrari R. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation. 2004;110:1209–1212. doi: 10.1161/01.CIR.0000136813.89036.21. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Severe Type 2 Diabetes Induces Reversible Modifications of Endothelial Progenitor Cells Which are Ameliorate by Glycemic Control

Affiliations

Severe Type 2 Diabetes Induces Reversible Modifications of Endothelial Progenitor Cells Which are Ameliorate by Glycemic Control

Authors

Affiliations

Abstract

Figures

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources

Other Literature Sources

Research Materials